Lonitoclax

lonitoclax · Lomond Therapeutics Holdings, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lonitoclax, covering 2025-12-26 to 2025-12-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients [Phase 1]